TrialThe Journal of pediatrics2012

Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.

Jorge Lujan-Zilbermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.